RenovoRx, Inc. SEC filings RNXT
RenovoRx, Inc. has 292 filings in SEC EDGAR's recent list, going back to Apr 10, 2013. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Other events
|
Aug 20, 2026 | Aug 20, 2026 |
| 8-K/A |
Amended current report
Results of operations
|
Aug 13, 2026 | Aug 12, 2026 |
| 8-K | Current report | Aug 12, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Other events
|
Aug 4, 2026 | Aug 4, 2026 |
| 8-K |
Current report
Listing notice
|
Jul 2, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 30, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
May 14, 2026 | May 14, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
Mar 30, 2026 | Mar 30, 2026 |
| 8-K |
Current report
Officer or director change
|
Mar 27, 2026 | Mar 27, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Mar 23, 2026 | Mar 23, 2026 |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 6, 2026 | Feb 6, 2026 |
| 8-K |
Current report
Listing notice
|
Jan 2, 2026 | Jan 2, 2026 |
| 8-K |
Current report
Material agreement
|
Nov 14, 2025 | Nov 14, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 13, 2025 | Nov 13, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 14, 2025 | Aug 14, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 25, 2025 | Jun 25, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
May 15, 2025 | May 15, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Apr 1, 2025 | Apr 1, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 10, 2025 | Feb 10, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 8-K |
Current report
Other events
|
Sep 25, 2024 | Sep 25, 2024 |
| 8-K |
Current report
Auditor change
|
Aug 16, 2024 | Aug 16, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 7, 2024 | Jun 7, 2024 |
| 8-K |
Current report
Auditor change, Officer or director change
|
May 3, 2024 | May 3, 2024 |
| 8-K |
Current report
Other events
|
Apr 18, 2024 | Apr 18, 2024 |
| 8-K |
Current report
Other events
|
Apr 16, 2024 | Apr 16, 2024 |
| 8-K |
Current report
Unregistered share sale, Regulation FD disclosure, Other events
|
Apr 15, 2024 | Apr 15, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 9, 2024 | Apr 9, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 14, 2024 | Mar 14, 2024 |
| 8-K |
Current report
Listing notice, Officer or director change
|
Feb 23, 2024 | Feb 23, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 9, 2024 | Feb 9, 2024 |
| 8-K |
Current report
Material agreement, Officer or director change, Regulation FD disclosure
|
Jan 29, 2024 | Jan 29, 2024 |
| 8-K |
Current report
Other events
|
Jan 2, 2024 | Jan 2, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Dec 18, 2023 | Dec 18, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2023 | Nov 14, 2023 |
| 8-K |
Current report
Other events
|
Nov 6, 2023 | Oct 31, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Sep 11, 2023 | Sep 7, 2023 |
| 8-K |
Current report
Listing notice
|
Aug 25, 2023 | Aug 21, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 17, 2023 | Aug 17, 2023 |
| 8-K |
Current report
Other events
|
Jun 29, 2023 | Jun 29, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2023 | Jun 9, 2023 |
| 8-K |
Current report
Results of operations
|
May 15, 2023 | May 15, 2023 |
| 8-K |
Current report
Officer or director change
|
Apr 27, 2023 | Apr 27, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Apr 3, 2023 | Mar 30, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
Mar 2, 2023 | Mar 2, 2023 |
| 8-K |
Current report
Other events
|
Jan 18, 2023 | Jan 18, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2022 | Nov 14, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 19, 2022 | Sep 19, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 15, 2022 | Aug 15, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 19, 2022 | Jul 13, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2022 | Jun 9, 2022 |
| 8-K |
Current report
Results of operations
|
May 16, 2022 | May 16, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 30, 2022 | Mar 30, 2022 |
| 8-K |
Current report
Auditor change
|
Dec 10, 2021 | Dec 7, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 15, 2021 | Nov 15, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Aug 31, 2021 | Aug 30, 2021 |
Showing 57 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- RNXT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Mountain View, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1574094
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.